HBM Healthcare Investments is an institutional investor (Conventional VCs) founded in 2001 and headquartered in Zug, Switzerland. HBM Healthcare Investments is a venture capital firm. Geographies of interest include the US and Europe. Invests in life sciences companies specializing in areas such as Diagnostics, BioTech, Biopharma and Medical Devices. Notable investments include PTC Therapeutics, Nabriva Therapeutics, Paratek Pharmaceuticals, Armo BioSciences. Notable portfolio companies: PTC Therapeutics, Nabriva Therapeutics, Paratek Pharmaceuticals, Armo BioSciences.

Stage

later-stage private (late clinical Phase II/III, profitable/cash flow-neutral), growth, follow-on, post-IPO public, buyout, later-stage private (late clinical Phase II/III, profitable/cash flow-neutral), growth, follow-on, post-IPO public, buyout

Check size

$5M-$50M

HQ

Zug, Switzerland

Founded

2001

Website

https://www.hbmhealthcare.com/en

LinkedIn

https://linkedin.com/company/hbm-healthcare-investments-ag

Twitter

https://twitter.com/hbmhealthcare

What they look for

later-stage companies with proof-of-concept or advanced products (Phase II+, market-ready); revenue-generating or cash flow-neutral preferred; strong business model, pipeline, technology, management; attractive valuation/risk-reward; global (primarily Europe, North America, Asia); HBM influence possible (board/majority stake)

Preparing to pitch HBM Healthcare Investments?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.